Patents by Inventor Amanda Jane Lyons

Amanda Jane Lyons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted thieno[2,3-d]pyrimidines as AMPA modulators
    Patent number: 8129397
    Abstract: The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and learning and memory disorders such as Alzheimer's disease.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: March 6, 2012
    Assignee: MSD Oss B.V.
    Inventors: Michael Gerard Gallagher, Craig C. Jamieson, Amanda Jane Lyons, John Kinnaird Ferguson Maclean, Elizabeth Margaret Moir
  • HETEROCYCLIC DERIVATIVES
    Publication number: 20090131455
    Abstract: The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and learning and memory disorders such as Alzheimer's disease.
    Type: Application
    Filed: November 12, 2008
    Publication date: May 21, 2009
    Inventors: Michael Gerard Gallagher, Craig C. Jamieson, Amanda Jane Lyons, John Kinnaird Ferguson Maclean, Elizabeth Margaret Moir
  • Serine protease inhibitors
    Patent number: 6855715
    Abstract: Compounds of formula (I) where R2, each X, L, Y, Cy, Lp, D and n are as defined in the specification, are serine protease inhibitors useful as antithrombotic agents.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: February 15, 2005
    Assignee: Eli Lilly and Company
    Inventors: John Walter Liebeschuetz, Amanda Jane Lyons, Christopher William Murray, Andrew David Rimmer, Stephen Clinton Young, Nicholas Paul Camp, Stuart Donald Jones, Phillip John Morgan, Simon James Richards, William Alexander Wylie, John Joseph Masters, Michael Robert Wiley